ScholarIQanswers from OpenAlex

Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis

PaperCitations, authors & open-access status

Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis have?

ScholarIQcitation count

Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis has 3 citations in the OpenAlex counts ScholarIQ stores.

When was Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis published?

ScholarIQyear

Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis has 2024 year in the ScholarIQ index.

What is the open-access status of Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis?

ScholarIQoa status

Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis has green oa status in the ScholarIQ index.

What is the DOI of Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis?

ScholarIQdoi

The DOI for Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis is on the source record.

What is the PMID of Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis?

ScholarIQpmid

The PMID for Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis is on the source record.

What is the OpenAlex record for Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis?

ScholarIQopenalex

The OpenAlex for Impact of 1‐year treatment with dupilumab on work productivity in Japanese patients with atopic dermatitis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial